“Clinical investigators flock to try to get coauthorship in multicenter trials, meta-analyses, and powerful guidelines to which they contribute little of essence,” notes John Ioannidis from Stanford University.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.